Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs linked to growth hormones may increase the chance of hair loss in women.

Gypenosides from Gynostemma pentaphyllum were found to have anti-aging effects, increasing skin collagen and reducing wrinkles.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The conclusion is that the technology for making "Biosedum plus" gel, which treats radiation skin damage, is validated.

The method effectively showed that the two exemestane preparations are bioequivalent.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

Gefitinib can cause hair loss without scarring.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.

A parasite molecule can speed up skin healing and reduce scarring.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

β-interferon injections for melanoma can cause excessive hair growth at the injection sites.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

GFC injections significantly improved hair growth and quality with minimal side effects.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

A rare EGFR mutation in newborns leads to severe health issues and early death.